WSH Incorporates Drug Approval Dates from BioMedTracker for Pharma Traders
The dataset will provide all relevant and potentially market-moving event dates around drug trials and approvals.
The vendor rolled out the data into Enchilada as a "soft launch" earlier this month, following a beta test period in January with a few hedge funds and other clients to whom WSH provides XML feeds.
In addition to FDA PDUFA (Prescription Drug User Fee Act) dates, BioMedTracker also provides WSH with other relevant information, such as the date when a drug enters review by the FDA, expected approval date plus any changes to that expected date, and the final notice of approval or denial for both
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
Capital markets’ demand for Google’s chips buoys cloud business
Google will begin delivering its TPUs to a select group of clients in their own datacenters later this year.
Waters Wavelength Ep. 351: MarketAxess’s Lee and Alexandre
This week, Spencer Lee and Julien Alexandre from MarketAxess join the podcast to discuss AI in fixed income trading.
Quants like Andrew Ang are making the case for AI agents
AI agents can boost human managers by analyzing investments, risks and portfolio choices at scale
Stuck in the sandbox: Why bank stablecoin projects struggle to get off the ground
Five years after a wave of banks announced stablecoin ambitions, most projects remain stuck in testing. WatersTechnology spoke to more than 25 experts to find out why an increasingly mature technology has yet to translate into production-grade bank infrastructure.
Northern Trust details its AI strategy
CEO Michael O’Grady says the firm’s strategy is anchored in hyper-personalization, AI-generated alpha, and infinite scalability.
The race to ‘financialize’ GPU compute set to ratchet up
The Waters Wrap: Anthony looks at two companies aiming to bring efficiency and transparency to the GPU compute market.
Deutsche Börse invests $200M in Kraken, DTCC advances cloud strategy, and more
A recap of this week’s major tech and data news in the capital markets.
Waters Wavelength Ep. 350: AI but make it about data basics
This week, Tony and Shen discuss how it’s all about getting back to basics, aka the data.